Shionogi Pharma To Market Combination Cold Remedy Pylon Hi
This article was originally published in PharmAsia News
Osaka-based Shionogi Pharma will launch cold medicine Pylon Hi on February 19th. Pylon Hi contains isopropylantipyrine (IPA) and acetaminophen, two cold remedy ingredients effective in reducing fever, combined with two herbal extracts: licorice and spruce used for relieving throat irritation and expelling phlegm. The hybrid medicine combining IPA with herbal medicines is made especially to reduce fever, relieve coughing, sore throats and headaches. (Click here for more-Japanese language
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.